Strata Skin Sciences (SSKN) Competitors $1.79 -0.03 (-1.87%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SSKN vs. FEMY, VVOS, DRIO, RVP, PETV, IRIX, NXGL, ALUR, NRXS, and NXLShould you be buying Strata Skin Sciences stock or one of its competitors? The main competitors of Strata Skin Sciences include Femasys (FEMY), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Retractable Technologies (RVP), PetVivo (PETV), IRIDEX (IRIX), NexGel (NXGL), Allurion Technologies (ALUR), NeurAxis (NRXS), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. Strata Skin Sciences vs. Its Competitors Femasys Vivos Therapeutics DarioHealth Retractable Technologies PetVivo IRIDEX NexGel Allurion Technologies NeurAxis Nexalin Technology Strata Skin Sciences (NASDAQ:SSKN) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment. Do analysts prefer SSKN or FEMY? Strata Skin Sciences currently has a consensus price target of $6.00, indicating a potential upside of 235.20%. Femasys has a consensus price target of $7.33, indicating a potential upside of 947.62%. Given Femasys' higher possible upside, analysts clearly believe Femasys is more favorable than Strata Skin Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in SSKN or FEMY? 32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 39.0% of Strata Skin Sciences shares are owned by insiders. Comparatively, 11.5% of Femasys shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation & earnings, SSKN or FEMY? Strata Skin Sciences has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStrata Skin Sciences$33.56M0.22-$10.09M-$2.84-0.63Femasys$1.63M13.99-$18.82M-$0.86-0.81 Which has more volatility and risk, SSKN or FEMY? Strata Skin Sciences has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Comparatively, Femasys has a beta of -2.58, indicating that its share price is 358% less volatile than the S&P 500. Does the media favor SSKN or FEMY? In the previous week, Strata Skin Sciences had 5 more articles in the media than Femasys. MarketBeat recorded 12 mentions for Strata Skin Sciences and 7 mentions for Femasys. Femasys' average media sentiment score of 0.28 beat Strata Skin Sciences' score of 0.02 indicating that Femasys is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Skin Sciences 1 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Femasys 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is SSKN or FEMY more profitable? Strata Skin Sciences has a net margin of -35.13% compared to Femasys' net margin of -1,113.72%. Strata Skin Sciences' return on equity of -203.84% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Strata Skin Sciences-35.13% -203.84% -31.30% Femasys -1,113.72%-713.74%-152.60% SummaryStrata Skin Sciences beats Femasys on 9 of the 15 factors compared between the two stocks. Get Strata Skin Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SSKN vs. The Competition Export to ExcelMetricStrata Skin SciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.46M$2.10B$5.70B$9.79BDividend YieldN/AN/A3.77%4.10%P/E Ratio-0.6337.0030.8625.27Price / Sales0.2210.18403.8888.61Price / CashN/A51.0625.2228.45Price / Book1.5010.879.516.00Net Income-$10.09M-$63.67M$3.26B$265.34M7 Day Performance-4.28%6.30%4.50%2.79%1 Month Performance-18.64%3.07%5.22%1.51%1 Year Performance-29.53%29.60%31.92%25.40% Strata Skin Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SSKNStrata Skin Sciences2.5277 of 5 stars$1.79-1.6%$6.00+235.2%-27.6%$7.46M$33.56M-0.63120Earnings ReportHigh Trading VolumeFEMYFemasys2.9678 of 5 stars$0.78-13.2%$7.33+845.7%-34.9%$29.04M$1.63M-0.9030Short Interest ↑Gap UpVVOSVivos Therapeutics1.5016 of 5 stars$4.58+4.1%$4.82+5.2%+76.4%$25.91M$15.03M-2.65160Upcoming EarningsDRIODarioHealth1.4674 of 5 stars$0.50-6.8%$2.00+297.6%-49.3%$24.57M$27.04M-0.90200RVPRetractable Technologies1.7258 of 5 stars$0.82+5.3%N/A-18.9%$24.43M$33.75M-1.51240Short Interest ↑PETVPetVivoN/A$0.86-1.1%N/A+35.2%$23.68M$1.05M-1.9120Gap DownIRIXIRIDEX1.2601 of 5 stars$1.26-3.1%N/A-40.2%$21.83M$48.67M-2.93120Earnings ReportNXGLNexGel1.3942 of 5 stars$2.65-1.5%N/A-6.9%$20.59M$8.69M-5.8910Earnings ReportShort Interest ↓ALURAllurion Technologies2.5465 of 5 stars$2.62-2.2%$22.83+771.5%-85.4%$19.99M$32.11M-0.21501Analyst DowngradeShort Interest ↓Gap UpNRXSNeurAxis2.8444 of 5 stars$2.43-1.2%$7.00+188.1%-24.2%$17.54M$2.93M-1.3219News CoverageShort Interest ↑NXLNexalin Technology3.1027 of 5 stars$0.89-1.1%$5.00+461.8%-19.7%$15.68M$170K-1.173Positive NewsShort Interest ↓ Related Companies and Tools Related Companies Femasys Alternatives Vivos Therapeutics Alternatives DarioHealth Alternatives Retractable Technologies Alternatives PetVivo Alternatives IRIDEX Alternatives NexGel Alternatives Allurion Technologies Alternatives NeurAxis Alternatives Nexalin Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SSKN) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access